Our study, therefore, provides a possible alternative avenue to boost antitumor IFNs via immune-cell secretion upon TLR9 stimulation, further supporting an antitumor role that TLR9 exhibits in establishing a tumor-suppressive microenvironment. The gene discussed is TLR9; the disease is neoplasm.